Indonesia approves emergency use of antiviral drugs to treat Covid-19 patients as death toll hits 11,371


A nurse wearing personal protective equipment (PPE) picks up a recovered patient of the coronavirus at a hotel designated to treat asymptomatic patients in Karawaci, Indonesia's Banten province. On Tuesday (Oct 6), Indonesia reported their Covid-19 total is above 311,000. - AFP

JAKARTA, Oct 6 (The Jakarta Post/ANN): Indonesia's Food and Drug Monitoring Agency (BPOM) has issued emergency use authorisation (EUA) for two antiviral drugs, favipiravir and remdesivir, to treat COVID-19 patients.

The BPOM also granted permits in September to several pharmaceutical companies to produce the drugs. PT Beta Pharmacon (Dexa Group) received a permit to produce favipiravir, locally sold under the Avigan brand.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

‘Don’t tell others how to do their jobs’: Inaction, disregard for safety led to Hong Kong’s deadly fire
India graveyard raid uncovers hidden cooking gas canisters amid shortage
Online sex trade targeting foreign tourists uncovered in Seoul crackdown
Singapore teen arrested after allegedly licking iJooz straw and placing it back in machine
Vietnam mulls cutting taxes on selected petroleum products to zero
DOE D-G, deputy arrive in court to face corruption charges
Bangkok’s soft-soil basin could amplify earthquake shaking by three to six times
Ringgit opens higher against US$ on softer NFP view
Cautious bounce on Bursa Malaysia amid cloudy outlook
South Korea, France to upgrade ties as Macron trip overshadowed by Middle East crisis

Others Also Read